ADVERTISEMENT
#Q4WithBQ | Suven Life Sciences' revenue contracts and loss widens on an yearly basis. Can company see improved performance in FY24?In conversation with Chairman & CEO Venkat Jasti. #BQLive
ADVERTISEMENT
RECOMMENDED FOR YOU
Aditya Birla Sun Life AMC Q4 Results Review - Equity Business Continues To Improve: Yes Securities
Apr 29, 2024
SBI Life Q4 Results Review - Consistently Delivering On Growth; Margin Improves: Nirmal Bang
Apr 29, 2024
SBI Life Q4 Results: Profit Rises 4%, Beats Estimates
Apr 26, 2024
Axis Bank Reappoints Amitabh Chaudhry As CEO
Apr 25, 2024
IPO Adda | Indegene Management On IPO Plans | NDTV Profit
IPO Adda | Aadhar Housing Finance MD & CEO Discusses Plans | NDTV Profit
NDTV Profit
IGX MD & CEO Rajesh Mediratta On New Small Scale LNG Contracts | NDTV Profit
NDTV Profit
TBO Tek To Launch Rs 1,550 Crore IPO | NDTV Profit
NDTV Profit
Indeed India's Sashi Kumar On Hiring Trends In India | NDTV Profit
NDTV Profit
Star Health's Q4 Report: Post-Hike Trends Discussed With Nilesh Kambli; Multiple Banking Partnerships
NDTV Profit
View All